May 15, 2019
Presented by: Shicheng Guo, PhD
Postdoctoral Fellow-Researcher, Marshfield Clinic Research Institute
About this seminar: Dr. Shicheng Guo is a Postdoctoral Fellow-Researcher at the Marshfield Clinic Research Institute (MCRI). He received his Ph.D. degree at Fudan University (Shanghai, China) in 2015 and completed two postdoctoral training positions at the School of Public Health (UThealth), University of Texas and the Department of Bioengineering, University of California, San Diego (UCSD). Dr. Guo started his Postdoctoral Fellow position in MCRI in October 2017 and works on genetic and epigenetic research studying human diseases in Dr. Steven Schrodi's lab with a focus on autoimmune diseases and cancers. He received the Computation and Informatics in Biology and Medicine (CIBM) training program Postdoctoral Fellowship in 2019 at UW-Madison. In the past several years, as the first and co-first author, Dr. Guo published his works in Nature Genetics, Blood, Journal of Medical Genetics, Clinical Epigenetics. Dr. Guo’s research interest in MCRI concentrates on genetics and epigenetics interaction to advance precision medicine. This work includes identifying epigenetic biomarkers for cancer and auto-immune diseases, novel genetic susceptibility and pharmacogenomics (PGx) and pharmaco-epigenomics (PeGx) genes for rheumatoid arthritis (RA), systemic sclerosis (SSc) and ankylosing spondylitis (AS) and related drug response, resistance and persistence.